Dr Josep Figueras on survival, access to treatments and the need for good data in oncology
MAPs represent a unique opportunity to gather evidence from a cohort of patients receiving the same treatment, across multiple countries prospectively before launch
Shire’s Sebastian Stachowiak on dealing with change and working for a fit-for-purpose orphan drug environment
The resulting cognitive dissonance from these events is making a lot of people feel very uncomfortable, but has the world really changed?
Are we neglecting the needs of those on the fringes of digital?
Crafting appropriate communications still requires the fundamentals to be done brilliantly, but increasingly a smarter integrated approach is key, says Claire Gillis
How marketing efforts in the pharma industry can improve outcomes while delivering increased value to healthcare providers and payers